CACNA1C and osteoporosis: To sum up, these results showed that intraperitoneal injection of Bay K8644 improved defective osteogenic differentiation and ameliorated osteoporosis symptom through targeting Cav1.2 channel and canonical Wnt pathway of BMMSCs (Figure 6f).